Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article



Synthesis and Biological Evaluation of New 2-(4-Fluorophenyl) Imidazol-5-ones as Anticancer Agents

Yasmin A. Abo-Elanwar, Amany S. Mostafa, Magda A. A. El-Sayed, Magda N. A. Nasr.

Abstract
Two series of imidazolones were designed, synthesized, and evaluated for their anticancer activity against four cancer cell lines; Hela, MCF-7, PC3 and HCT-116, where four compounds 6, 25, 26 and 29 showed good potency against the whole panel. Compound 30 showed a cytotoxic effect against PC3 cell lines comparable to that of the standard doxorubicin with IC50= 8.15然; while compounds 4 and 18 showed moderate activity with IC50 range of 10.58-11.45 然. Enzyme inhibition assay was implemented against CDK2A and VEGFR-2 that gave varied activities. Compound 6 exhibited the highest inhibitory activity against VEGFR-2; with IC50 value of 67 nM and moderate inhibition against CDK2A, while compound 26 achieved the best result against CDK2A with IC50 value of 0.66 然.

Key words: Imidazlone; Chalcones; Anticancer; VEGFR-2; CDK2A



Share this Article


Advertisement
Oxidants and Antioxidants in Medical Science

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.